3月10日 - ** 基因测序设备制造商IlluminaILMN.O的股价在延时交易中上涨3.7
** 在中国宣布禁止进口其基因测序仪器后，公司将削减1亿美元开支 (link)
** ILMN表示，节省开支将减轻该公司大中华区业务收入和相关营业收入可能减少的影响。
** 公司还下调了2025财年调整后每股利润的预期，每股利润约为4.50美元，而之前的预期为每股4.50美元至4.65美元。
** 首席财务官安库尔-丁格拉（Ankur Dhingra）说："我们新的 2025 财年指导对来自中国的进一步盈利贡献有限，并假定我们目前看到的宏观趋势将持续下去。
** 截至上次收盘，股价累计下跌 35.7
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.